Status
Conditions
Treatments
About
The purpose of this study is to characterize the safety of ONIVYDE when used under standard clinical practice in South Korea; and to describe effectiveness in patients receiving ONIVYDE in combination with 5-fluorouracil (5-FU) and leucovorin for the treatment of metastatic pancreatic cancer under standard clinical care in South Korea.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients who are prescribed ONIVYDE per investigator's judgment shall be included if:
Exclusion criteria
94 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal